Hongchao Pan on an Update on 5 Years of Endocrine Therapy for Early Breast Cancer – The ASCO Post

2019 San Antonio Breast Cancer Symposium Hongchao Pan, PhD, of the University of Oxford, discusses an analysis of 86,000 women in the Early Breast Cancer Trialists’ Collaborative Group database, which showed that the risk of distant recurrence 20 years after a diagnosis of node-negative, estrogen receptor–negative early-stage breast cancer in women who discontinued…

Read the full article here

Related Articles